Poop transplant trial aims to tame diabetes and heart disease
NCT ID NCT07421947
Summary
This small pilot study is testing if a fecal microbiota transplant (FMT) can change the gut bacteria of people who have both type 2 diabetes and stable coronary artery disease. Researchers want to see if altering the gut microbiome can improve metabolic health and reduce inflammation. The main goal is to measure changes in gut bacteria six months after the transplant procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital Zurich
Zurich, Canton of Zurich, 8091, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.